Last updated: September 5, 2025
Introduction
South Korea’s patent system offers a robust landscape for pharmaceutical innovations, with KR101353857 representing a significant patent within this domain. This patent illustrates the strategic approaches in drug patenting, especially within the competitive Korean pharmaceutical market, which emphasizes both innovation and exclusivity. This analysis dissects the patent’s scope, claims, and its position within the overall patent landscape, providing essential insights for stakeholders—be they patentees, competitors, or investors.
Overview of Patent KR101353857
KR101353857, granted in South Korea, pertains to a novel pharmaceutical composition or method involving a specific compound or combination. While details are proprietary, typical patent filings under this family focus on innovative chemical entities, formulations, or therapeutic methods. The patent date indicates its filing and grant period, providing context for its legal standing and competitive lifespan.
Scope of the Patent
Legal Boundaries and Coverage
The scope of KR101353857 is primarily defined by its claims, which demarcate the boundaries of legal protection. Claims specify the inventive features and identify what the patentholder exclusively controls, preventing others from manufacturing, using, or selling the patented invention without authorization.
The scope includes:
- Chemical Composition Claims: Covering the structure, derivatives, or salts of specific molecules.
- Method Claims: Pertaining to manufacturing processes or therapeutic methods involving the compound.
- Formulation Claims: Encompassing specific pharmaceutical compositions with defined excipients or delivery mechanisms.
Claims Structure
Generally, pharmaceutical patents like KR101353857 comprise:
- Independent claims: Broadly define the core inventive concept, establishing the minimum scope.
- Dependent claims: Narrower, referencing the independent claims, add specific features or embodiments.
The scope is heavily influenced by the breadth of these claims. Broader claims offer wider protection but are more susceptible to invalidation for lack of novelty or inventive step, whereas narrower claims provide specific coverage with higher enforceability.
Analysis of the Claims
Claim Language and Interpretation
The precise language employed in patent claims determines enforceability and scope. For KR101353857:
- Structural Claims: Likely describe specific chemical structures or classes of compounds with defined substitutions.
- Use Cases: Claims may specify therapeutic indications or administration routes, such as treating particular diseases.
- Formulation Details: Claims could include specific excipient combinations, dosages, or delivery systems.
Novelty and Inventive Step
A patent’s validity hinges on:
- Novelty: The claimed drug must not have been publicly disclosed before the filing date or priority date. Prior art searches suggest that the patent overcomes prior disclosures by introducing a unique chemical modification or formulation.
- Inventive Step: The invention must not be obvious to a person skilled in the art. The patent demonstrates inventive contribution via a non-trivial modification or unexpected therapeutic benefit.
Scope Evolution and Narrowing
During prosecution or post-grant, claims may be amended to align with prior art or establish clear boundaries, optimizing enforceability without overly restricting the patent’s coverage.
Patent Landscape and Competitive Context
Major Patent Families and Related Patents
KR101353857 exists within a constellation of patents covering similar chemical entities, formulations, and methods, often held by large pharmaceutical companies or research institutions in Korea and globally. Key considerations include:
- Patent Families: International counterparts might be filed via PCT or regional routes, extending protection beyond South Korea.
- Blocking Patents: Related patents could cover alternative compounds or delivery systems, creating a landscape of “patent fences” around specific therapeutic classes.
- Freedom to Operate (FTO): Critical analysis is required to determine whether KR101353857 infringes or is infringed upon by existing patents.
Innovation Trends and Patent Filing Strategies
Korean pharmaceutical entities typically adopt comprehensive patent strategies, including:
- Filing multiple patents on incremental improvements.
- Securing broad composition claims and method claims to capitalize on different market segments.
- Combining chemical and formulation patents for comprehensive market protection.
Legal and Market Implications
The patent’s strength depends on:
- Claim Breadth and Clarity: Clear, well-supported claims withstand legal scrutiny.
- Settlement and Litigation Trends: The patent landscape shows active enforcement, with litigations often centered around claim scope disputes.
- Market Exclusivity and Commercialization: Strong patent coverage prolongs market dominance, vital for recouping R&D investments.
Implications for Stakeholders
- Pharmaceutical Developers: Must evaluate patent scope to design non-infringing alternatives or consider licensing opportunities.
- Competitors: Need to map competing patents to identify Free-to-Operate zones.
- Investors: Should assess patent strength and landscape to inform licensing, partnerships, or exit strategies.
Key Takeaways
- KR101353857 achieves patent protection through well-defined claims covering composition, method, and formulation, with an emphasis on structure-specific or therapeutic innovations.
- The patent’s scope is strategically tailored, balancing broad coverage with validity considerations, reinforced through dependent claims.
- A dense landscape of related patents necessitates careful freedom to operate analysis, especially considering potential infringement risks or licensing opportunities.
- Ongoing patent prosecution and litigation trends emphasize the importance of claim quality and strategic patent family management.
- To maximize value, patent holders should pursue comprehensive geographic protection and closely monitor competing filings to maintain market exclusivity.
FAQs
1. What is the primary focus of patent KR101353857?
It most likely claims a novel chemical compound or pharmaceutical formulation with specific therapeutic applications, although exact details depend on the patent’s claims and description.
2. How broad are the claims typically in such pharmaceutical patents?
Independent claims tend to be broad to maximize protection, covering the core compound or method, while dependent claims narrow down to specific embodiments or variants, balancing enforceability with scope.
3. How does KR101353857 compare with international patents?
The patent may be part of a broader patent family with equivalents filed via PCT or regional routes to secure international protection, but specific comparison depends on granted equivalents’ claim language and scope.
4. What are the risks associated with patent landscape complexity?
Overlapping patents or prior art can lead to invalidation or design-around strategies, underscoring the importance of comprehensive patent landscape analysis before commercialization.
5. What strategic steps should patentees take post-grant?
They should consider further claims broadening, filing abroad, monitoring third-party filings, and enforcing their rights against infringers to maintain market dominance.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database [1].
- Patent family and citation analysis reports.
- Industry patent landscape reports on Korean pharmaceutical patents.
- Legal literature on patent claim strategy and validity considerations.
Conclusion
Patent KR101353857 exemplifies strategic patent claim drafting within Korea’s pharmaceutical patent landscape. Its scope balances innovation and legal robustness, supported by a complex network of related patents. For stakeholders, understanding these nuances enables informed decisions on licensing, R&D, and competitive positioning, ensuring the patent remains a valuable asset in the evolving Korean pharma market.
